The increased Rab5 levels in these cancer cells may overwhelm Rab5 regulatory proteins such as GAPs—allowing for an increase in active Rab5 as compared to normal cells and disruption of the temporal regulation of endosomal traffic. This evidence concerns the gene RAB5A and cancer.